Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15023167rdf:typepubmed:Citationlld:pubmed
pubmed-article:15023167lifeskim:mentionsumls-concept:C1708335lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C0358591lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C0937846lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C0018517lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C0439590lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C0442113lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:15023167lifeskim:mentionsumls-concept:C1455363lld:lifeskim
pubmed-article:15023167pubmed:issue6lld:pubmed
pubmed-article:15023167pubmed:dateCreated2004-3-16lld:pubmed
pubmed-article:15023167pubmed:abstractTextProton pump inhibitors control gastric acidity better during the day than at night, when nocturnal acid breakthrough can occur. Tenatoprazole is a novel proton pump inhibitor with a seven-fold longer plasma half-life. Aim : To compare the effects of tenatoprazole 20 mg (T20), tenatoprazole 40 mg (T40) and esomeprazole 40 mg (E40) on intragastric acidity in healthy volunteers.lld:pubmed
pubmed-article:15023167pubmed:languageenglld:pubmed
pubmed-article:15023167pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023167pubmed:citationSubsetIMlld:pubmed
pubmed-article:15023167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15023167pubmed:statusMEDLINElld:pubmed
pubmed-article:15023167pubmed:monthMarlld:pubmed
pubmed-article:15023167pubmed:issn0269-2813lld:pubmed
pubmed-article:15023167pubmed:authorpubmed-author:GalmicheJ PJPlld:pubmed
pubmed-article:15023167pubmed:authorpubmed-author:FiorentiniPPlld:pubmed
pubmed-article:15023167pubmed:authorpubmed-author:Bruley Des...lld:pubmed
pubmed-article:15023167pubmed:authorpubmed-author:HomerinMMlld:pubmed
pubmed-article:15023167pubmed:authorpubmed-author:DucrottéPPlld:pubmed
pubmed-article:15023167pubmed:authorpubmed-author:TaccoenAAlld:pubmed
pubmed-article:15023167pubmed:authorpubmed-author:VavasseurFFlld:pubmed
pubmed-article:15023167pubmed:authorpubmed-author:Sacher-Huveli...lld:pubmed
pubmed-article:15023167pubmed:issnTypePrintlld:pubmed
pubmed-article:15023167pubmed:day15lld:pubmed
pubmed-article:15023167pubmed:volume19lld:pubmed
pubmed-article:15023167pubmed:ownerNLMlld:pubmed
pubmed-article:15023167pubmed:authorsCompleteYlld:pubmed
pubmed-article:15023167pubmed:pagination655-62lld:pubmed
pubmed-article:15023167pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:meshHeadingpubmed-meshheading:15023167...lld:pubmed
pubmed-article:15023167pubmed:year2004lld:pubmed
pubmed-article:15023167pubmed:articleTitleTenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers.lld:pubmed
pubmed-article:15023167pubmed:affiliationCIC-INSERM, CHU de Nantes, Nantes, France. galmiche@easynet.frlld:pubmed
pubmed-article:15023167pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15023167pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15023167pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15023167pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:15023167pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15023167pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15023167lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15023167lld:pubmed